Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 519

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression

Cirri, Paolo, Chiarugi, Paola·2012·Cancer and Metastasis Reviews
DOI 10.1007/s10555-011-9340-x
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10555-011-9340-x

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 100

  1. Desmouliere, A., Redard, M., Darby, I., & Gabbiani, G. (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. American Journal of Pathology, 146(1), 56–66.
  2. Pietras, K., & Ostman, A. (2010). Hallmarks of cancer: Interactions with the tumor stroma. Experimental Cell Research, 316(8), 1324–1331. · DOI · Paper page
  3. Micke, P., & Ostman, A. (2004). Tumour–stroma interaction: Cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer, 45(Suppl 2), S163–S175. · DOI · Paper page
  4. O’Brien, P., & O’Connor, B. F. (2008). Seprase: An overview of an important matrix serine protease. Biochimica et Biophysica Acta, 1784(9), 1130–1145. · DOI
  5. Hasebe, T., Tamura, N., Okada, N., Hojo, T., Akashi-Tanaka, S., Shimizu, C., et al. (2010). p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy. Human Pathology, 41(2), 262–270. · DOI
  6. Nakao, M., Ishii, G., Nagai, K., Kawase, A., Kenmotsu, H., Kon-No, H., et al. (2009). Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma. Cancer, 115(12), 2732–2743. · DOI
  7. Utispan, K., Thuwajit, P., Abiko, Y., Charngkaew, K., Paupairoj, A., Chau-in, S., et al. (2010). Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Molecular Cancer, 9, 13. · DOI
  8. Witkiewicz, A. K., Dasgupta, A., Sotgia, F., Mercier, I., Pestell, R. G., Sabel, M., et al. (2009). An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. American Journal of Pathology, 174(6), 2023–2034. · DOI · Paper page
  9. Yamanashi, T., Nakanishi, Y., Fujii, G., Akishima-Fukasawa, Y., Moriya, Y., Kanai, Y., et al. (2009). Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Oncology, 77(1), 53–62. · DOI
  10. Trimboli, A. J., Cantemir-Stone, C. Z., Li, F., Wallace, J. A., Merchant, A., Creasap, N., et al. (2009). Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature, 461(7267), 1084–1091. · DOI · Paper page
  11. Kiaris, H., Chatzistamou, I., Trimis, G., Frangou-Plemmenou, M., Pafiti-Kondi, A., & Kalofoutis, A. (2005). Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis. Cancer Research, 65(5), 1627–1630. · DOI · Paper page
  12. Anderberg, C., & Pietras, K. (2009). On the origin of cancer-associated fibroblasts. Cell Cycle, 8(10), 1461–1462. · DOI
  13. Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M. L., & Gabbiani, G. (2007). The myofibroblast: One function, multiple origins. American Journal of Pathology, 170(6), 1807–1816. · DOI · Paper page
  14. McAnulty, R. J. (2007). Fibroblasts and myofibroblasts: Their source, function and role in disease. The International Journal of Biochemistry & Cell Biology, 39(4), 666–671. · DOI · Paper page
  15. Ostman, A., & Augsten, M. (2009). Cancer-associated fibroblasts and tumor growth—Bystanders turning into key players. Current Opinion in Genetics and Development, 19(1), 67–73. · DOI · Paper page
  16. De, W. O., & Mareel, M. (2003). Role of tissue stroma in cancer cell invasion. The Journal of Pathology, 200(4), 429–447. · DOI · Paper page
  17. Lohr, M., Schmidt, C., Ringel, J., Kluth, M., Muller, P., Nizze, H., et al. (2001). Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Research, 61(2), 550–555.
  18. Bronzert, D. A., Pantazis, P., Antoniades, H. N., Kasid, A., Davidson, N., Dickson, R. B., et al. (1987). Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proceedings of the National Academy of Sciences of the United States of America, 84(16), 5763–5767. · DOI · Paper page
  19. Shao, Z. M., Nguyen, M., & Barsky, S. H. (2000). Human breast carcinoma desmoplasia is PDGF initiated. Oncogene, 19(38), 4337–4345. · DOI · Paper page
  20. Strutz, F., Zeisberg, M., Hemmerlein, B., Sattler, B., Hummel, K., Becker, V., et al. (2000). Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney International, 57(4), 1521–1538. · DOI · Paper page
  21. Cat, B., Stuhlmann, D., Steinbrenner, H., Alili, L., Holtkotter, O., Sies, H., et al. (2006). Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. Journal of Cell Science, 119(Pt 13), 2727–2738. · DOI
  22. Stuhlmann, D., Steinbrenner, H., Wendlandt, B., Mitic, D., Sies, H., & Brenneisen, P. (2004). Paracrine effect of TGF-beta1 on downregulation of gap junctional intercellular communication between human dermal fibroblasts. Biochemical and Biophysical Research Communications, 319(2), 321–326. · DOI
  23. Giannoni, E., Bianchini, F., Calorini, L., & Chiarugi, P. (2011). Cancer associated fibroblasts exploit reactive oxygen species through a pro-inflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxidand & Redox Signaling, 14, 2361–2371. · DOI · Paper page
  24. Georges, P. C., & Janmey, P. A. (2005). Cell type-specific response to growth on soft materials. Journal of Applied Physiology, 98(4), 1547–1553. · DOI · Paper page
  25. Assoian, R. K., & Klein, E. A. (2008). Growth control by intracellular tension and extracellular stiffness. Trends in Cell Biology, 18(7), 347–352. · DOI · Paper page
  26. Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., et al. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell, 8(3), 241–254. · DOI · Paper page
  27. Chun, T. H., Hotary, K. B., Sabeh, F., Saltiel, A. R., Allen, E. D., & Weiss, S. J. (2006). A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell, 125(3), 577–591. · DOI · Paper page
  28. Kauppila, S., Stenback, F., Risteli, J., Jukkola, A., & Risteli, L. (1998). Aberrant type I and type III collagen gene expression in human breast cancer in vivo. The Journal of Pathology, 186(3), 262–268. · doi:10.1002/(sici)1096-9896(1998110)186:3<262::aid-path191>3.0.co;2-3
  29. Hasebe, T., Sasaki, S., Imoto, S., Mukai, K., Yokose, T., & Ochiai, A. (2002). Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: A prospective observational study. Modern Pathology, 15(5), 502–516. · DOI
  30. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820–827. · DOI · Paper page
  31. Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell, 139(5), 891–906. · DOI · Paper page
  32. Santhanam, A. N., Baker, A. R., Hegamyer, G., Kirschmann, D. A., & Colburn, N. H. (2010). Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene, 29(27), 3921–3932. · DOI · Paper page
  33. Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., et al. (2009). Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science, 324(5933), 1457–1461. · DOI · Paper page
  34. Shieh, A. C., Rozansky, H. A., Hinz, B., & Swartz, M. A. (2011). Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Research, 71(3), 790–800. · DOI · Paper page
  35. Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., & Smith, J. W. (2000). Ligand binding to integrins. Journal of Biological Chemistry, 275(29), 21785–21788. · DOI · Paper page
  36. Velling, T., Risteli, J., Wennerberg, K., Mosher, D. F., & Johansson, S. (2002). Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. Journal of Biological Chemistry, 277(40), 37377–37381. · DOI · Paper page
  37. Pankov, R., & Yamada, K. M. (2002). Fibronectin at a glance. Journal of Cell Science, 115(Pt 20), 3861–3863. · DOI · Paper page
  38. Chen, S. H., Lin, C. Y., Lee, L. T., Chang, G. D., Lee, P. P., Hung, C. C., et al. (2010). Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells. Anticancer Research, 30(10), 4177–4186.
  39. Mitra, A. K., Sawada, K., Tiwari, P., Mui, K., Gwin, K., & Lengyel, E. (2011). Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene, 30(13), 1566–1576. · DOI · Paper page
  40. Kobayashi, N., Miyoshi, S., Mikami, T., Koyama, H., Kitazawa, M., Takeoka, M., et al. (2010). Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. Cancer Research, 70(18), 7073–7083. · DOI · Paper page
  41. Wang, W., Li, Q., Yamada, T., Matsumoto, K., Matsumoto, I., Oda, M., et al. (2009). Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors. Clinical Cancer Research, 15(21), 6630–6638. · DOI · Paper page
  42. Matsumoto, K., & Nakamura, T. (2006). Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions. International Journal of Cancer, 119(3), 477–483. · DOI · Paper page
  43. Matsumoto, K., Okazaki, H., & Nakamura, T. (1995). Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. Journal of Biochemistry, 117(2), 458–464. · DOI
  44. Gerber, P. A., Hippe, A., Buhren, B. A., Muller, A., & Homey, B. (2009). Chemokines in tumor-associated angiogenesis. Biological Chemistry, 390(12), 1213–1223. · DOI
  45. Matsuo, Y., Ochi, N., Sawai, H., Yasuda, A., Takahashi, H., Funahashi, H., et al. (2009). CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. International Journal of Cancer, 124(4), 853–861. · DOI · Paper page
  46. Augsten, M., Hagglof, C., Olsson, E., Stolz, C., Tsagozis, P., Levchenko, T., et al. (2009). CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 106(9), 3414–3419. · DOI · Paper page
  47. Roy, R., Yang, J., & Moses, M. A. (2009). Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. Journal of Clinical Oncology, 27(31), 5287–5297. · DOI · Paper page
  48. Vosseler, S., Lederle, W., Airola, K., Obermueller, E., Fusenig, N. E., & Mueller, M. M. (2009). Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. International Journal of Cancer, 125(10), 2296–2306. · DOI
  49. Lederle, W., Hartenstein, B., Meides, A., Kunzelmann, H., Werb, Z., Angel, P., et al. (2010). MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis, 31(7), 1175–1184. · DOI
  50. Dean, J. P., & Nelson, P. S. (2008). Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis. British Journal of Cancer, 98(2), 245–249. · DOI
  51. Blasi, F., & Sidenius, N. (2010). The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling. FEBS Letters, 584(9), 1923–1930. · DOI · Paper page
  52. Noskova, V., Ahmadi, S., Asander, E., & Casslen, B. (2009). Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms. Gynecologic Oncology, 115(1), 121–126. · DOI
  53. Davalos, A. R., Coppe, J. P., Campisi, J., & Desprez, P. Y. (2010). Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Reviews, 29(2), 273–283. · DOI · Paper page
  54. Lee, C. (1996). Role of androgen in prostate growth and regression: Stromal–epithelial interaction. The Prostate. Supplement, 6, 52–56. · DOI
  55. Chang, S. M., & Chung, L. W. (1989). Interaction between prostatic fibroblast and epithelial cells in culture: Role of androgen. Endocrinology, 125(5), 2719–2727. · DOI · Paper page
  56. Cano, P., Godoy, A., Escamilla, R., Dhir, R., & Onate, S. A. (2007). Stromal–epithelial cell interactions and androgen receptor–coregulator recruitment is altered in the tissue microenvironment of prostate cancer. Cancer Research, 67(2), 511–519. · DOI
  57. Ricciardelli, C., Choong, C. S., Buchanan, G., Vivekanandan, S., Neufing, P., Stahl, J., et al. (2005). Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease. Prostate, 63(1), 19–28. · DOI
  58. Henshall, S. M., Quinn, D. I., Lee, C. S., Head, D. R., Golovsky, D., Brenner, P. C., et al. (2001). Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Research, 61(2), 423–427.
  59. Zhao, Y., Nichols, J. E., Valdez, R., Mendelson, C. R., & Simpson, E. R. (1996). Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Molecular Endocrinology, 10(11), 1350–1357. · DOI · Paper page
  60. Simpson, E. R., & Davis, S. R. (2001). Minireview: Aromatase and the regulation of estrogen biosynthesis—Some new perspectives. Endocrinology, 142(11), 4589–4594. · DOI
  61. Santen, R. J., Santner, S. J., Pauley, R. J., Tait, L., Kaseta, J., Demers, L. M., et al. (1997). Estrogen production via the aromatase enzyme in breast carcinoma: Which cell type is responsible? The Journal of Steroid Biochemistry and Molecular Biology, 61(3–6), 267–271. · DOI
  62. Howell, A., Cuzick, J., Baum, M., Buzdar, A., Dowsett, M., Forbes, J. F., et al. (2005). Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet, 365(9453), 60–62. · DOI · Paper page
  63. De, W. O., Demetter, P., Mareel, M., & Bracke, M. (2008). Stromal myofibroblasts are drivers of invasive cancer growth. International Journal of Cancer, 123(10), 2229–2238. · DOI · Paper page
  64. Kalluri, R. (2009). EMT: When epithelial cells decide to become mesenchymal-like cells. The Journal of Clinical Investigation, 119(6), 1417–1419. · DOI · Paper page
  65. Thiery, J. P., Acloque, H., Huang, R. Y., & Nieto, M. A. (2009). Epithelial–mesenchymal transitions in development and disease. Cell, 139(5), 871–890. · DOI · Paper page
  66. Blick, T., Hugo, H., Widodo, E., Waltham, M., Pinto, C., Mani, S. A., et al. (2010). Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. Journal of Mammary Gland Biology and Neoplasia, 15(2), 235–252. · DOI · Paper page
  67. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704–715. · DOI · Paper page
  68. Klarmann, G. J., Hurt, E. M., Mathews, L. A., Zhang, X., Duhagon, M. A., Mistree, T., et al. (2009). Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clinical & Experimental Metastasis, 26(5), 433–446. · DOI · Paper page
  69. Visvader, J. E., & Lindeman, G. J. (2008). Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nature Reviews. Cancer, 8(10), 755–768. · DOI · Paper page
  70. Liao, C. P., Adisetiyo, H., Liang, M., & Roy-Burman, P. (2010). Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Research, 70(18), 7294–7303. · DOI
  71. Wu, Y., Deng, J., Rychahou, P. G., Qiu, S., Evers, B. M., & Zhou, B. P. (2009). Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell, 15(5), 416–428. · DOI · Paper page
  72. De, W. O., Pauwels, P., De, C. B., Sabbah, M., Emami, S., Redeuilh, G., et al. (2008). Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front. Histochemistry and Cell Biology, 130(3), 481–494. · DOI · Paper page
  73. Patocs, A., Zhang, L., Xu, Y., Weber, F., Caldes, T., Mutter, G. L., et al. (2007). Breast-cancer stromal cells with TP53 mutations and nodal metastases. The New England Journal of Medicine, 357(25), 2543–2551. · DOI · Paper page
  74. Vander Heiden, M. G., Locasale, J. W., Swanson, K. D., Sharfi, H., Heffron, G. J., Amador-Noguez, D., et al. (2010). Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science, 329(5998), 1492–1499. · DOI · Paper page
  75. Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O’Meally, R., et al. (2011). Pyruvate kinase M2 Is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell, 145(5), 732–744. · DOI · Paper page
  76. Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., et al. (2009). The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle, 8(23), 3984–4001. · DOI · Paper page
  77. Martinez-Outschoorn, U. E., Trimmer, C., Lin, Z., Whitaker-Menezes, D., Chiavarina, B., Zhou, J., et al. (2010). Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle, 9(17), 3515–3533. · DOI · Paper page
  78. Koukourakis, M. I., Giatromanolaki, A., Harris, A. L., & Sivridis, E. (2006). Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Research, 66(2), 632–637. · DOI · Paper page
  79. Garzon, R., Marcucci, G., & Croce, C. M. (2010). Targeting microRNAs in cancer: Rationale, strategies and challenges. Nature Reviews. Drug Discovery, 9(10), 775–789. · DOI · Paper page
  80. Tazawa, H., Kagawa, S., & Fujiwara, T. (2011). MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors. Expert Opinion on Biological Therapy, 11(2), 145–155. · DOI
  81. Musumeci, M., Coppola, V., Addario, A., Patrizii, M., Maugeri-Sacca, M., Memeo, L., et al. (2011). Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene, 30, 4231–4242. · DOI · Paper page
  82. Nielsen, B. S., Jorgensen, S., Fog, J. U., Sokilde, R., Christensen, I. J., Hansen, U., et al. (2011). High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clinical & Experimental Metastasis, 28(1), 27–38. · DOI · Paper page
  83. Yao, Q., Cao, S., Li, C., Mengesha, A., Kong, B., & Wei, M. (2011). Micro-RNA-21 regulates TGF-beta-induced myofibroblast differentiation by targeting PDCD4 in tumor–stroma interaction. International Journal of Cancer, 128(8), 1783–1792. · DOI
  84. Aprelikova, O., Yu, X., Palla, J., Wei, B. R., John, S., Yi, M., et al. (2010). The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle, 9(21), 4387–4398. · DOI
  85. Lim, P. K., Bliss, S. A., Patel, S. A., Taborga, M., Dave, M. A., Gregory, L. A., et al. (2011). Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Research, 71(5), 1550–1560. · DOI · Paper page
  86. Grange, C., Tapparo, M., Collino, F., Vitillo, L., Damasco, C., Deregibus, M. C., et al. (2011). Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung pre-metastatic niche. Cancer Research, 71, 5346–5356. · DOI · Paper page
  87. Nguyen, D. X., Bos, P. D., & Massague, J. (2009). Metastasis: From dissemination to organ-specific colonization. Nature Reviews. Cancer, 9(4), 274–284. · DOI · Paper page
  88. Tu, S. M., Lin, S. H., & Logothetis, C. J. (2002). Stem-cell origin of metastasis and heterogeneity in solid tumours. The Lancet Oncology, 3(8), 508–513. · DOI · Paper page
  89. Psaila, B., & Lyden, D. (2009). The metastatic niche: Adapting the foreign soil. Nature Reviews. Cancer, 9(4), 285–293. · DOI · Paper page
  90. Duda, D. G., Duyverman, A. M., Kohno, M., Snuderl, M., Steller, E. J., Fukumura, D., et al. (2010). Malignant cells facilitate lung metastasis by bringing their own soil. Proceedings of the National Academy of Sciences of the United States of America, 107, 21677–21682. · DOI · Paper page
  91. Sung, S. Y., Hsieh, C. L., Law, A., Zhau, H. E., Pathak, S., Multani, A. S., et al. (2008). Coevolution of prostate cancer and bone stroma in three-dimensional coculture: Implications for cancer growth and metastasis. Cancer Research, 68(23), 9996–10003. · DOI · Paper page
  92. Pietras, K., Pahler, J., Bergers, G., & Hanahan, D. (2008). Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Medicine, 5(1), e19. · DOI · Paper page
  93. Wu, M. P., Young, M. J., Tzeng, C. C., Tzeng, C. R., Huang, K. F., Wu, L. W., et al. (2008). A novel role of thrombospondin-1 in cervical carcinogenesis: Inhibit stroma reaction by inhibiting activated fibroblasts from invading cancer. Carcinogenesis, 29(6), 1115–1123. · DOI
  94. Wen, J., Matsumoto, K., Taniura, N., Tomioka, D., & Nakamura, T. (2004). Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice. Cancer Gene Therapy, 11(6), 419–430. · DOI
  95. Kim, K. J., Wang, L., Su, Y. C., Gillespie, G. Y., Salhotra, A., Lal, B., et al. (2006). Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clinical Cancer Research, 12(4), 1292–1298. · DOI
  96. Crawford, Y., Kasman, I., Yu, L., Zhong, C., Wu, X., Modrusan, Z., et al. (2009). PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell, 15(1), 21–34. · DOI · Paper page
  97. Sato, N., Maehara, N., & Goggins, M. (2004). Gene expression profiling of tumor–stromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Research, 64(19), 6950–6956. · DOI
  98. Hu, M., Peluffo, G., Chen, H., Gelman, R., Schnitt, S., & Polyak, K. (2009). Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proceedings of the National Academy of Sciences of the United States of America, 106(9), 3372–3377. · DOI · Paper page
  99. Mann, J., Oakley, F., Akiboye, F., Elsharkawy, A., Thorne, A. W., & Mann, D. A. (2007). Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: Implications for wound healing and fibrogenesis. Cell Death and Differentiation, 14(2), 275–285. · DOI · Paper page
  100. Scott, A. M., Wiseman, G., Welt, S., Adjei, A., Lee, F. T., Hopkins, W., et al. (2003). A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clinical Cancer Research, 9(5), 1639–1647.

Cited by

See all 519

Metadata

Authors
Cirri, P., & Chiarugi, P.
Venue
Cancer and Metastasis Reviews
Publisher
Springer Science and Business Media LLC
Published
2011-11-19
Volume
31
Issue
1-2
Pages
195-208
ISSN
  • 0167-7659 (ISSN-L)
  • 1573-7233
DOI
10.1007/s10555-011-9340-x
OpenAlex
W1973519930
Cited by
519
References
24
FWCI
3.80
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. https://app.cochat.ai/papers/10.1007/s10555-011-9340-x
The paper
Cirri, P., & Chiarugi, P. (2012). Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-011-9340-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.